Navigation Links
Synthetic Biologics to Participate in Fireside Chat at RBC Capital Markets' Global Healthcare Conference
Date:2/16/2016

ROCKVILLE, Md., Feb. 16, 2016 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on developing therapeutics to protect the gut microbiome, announced today that Jeffrey Riley, President & Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat with the Company's covering analyst, Adnan Butt, at the 2016 RBC Capital Markets Global Healthcare Conference on Tuesday, February 23, at 4:35 p.m. (ET) in the Holmes II room at the New York Palace Hotel in New York.

A live webcast of Synthetic Biologics' fireside chat may be accessed by logging onto the internet at https://www.veracast.com/webcasts/rbc/healthcare2016/17116241334.cfm. After the discussion, a replay will be archived and accessible for 90 days at the same website.

About Synthetic Biologics, Inc.

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a clinical stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company's lead candidates in Phase 2 development include: (1) SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and (2) SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C). In collaboration with Intrexon Corporation (NYSE: XON), the Company is developing a preclinical stage monoclonal antibody for the prevention and treatment of Pertussis, and discovery stage biotherapeutics for the treatment of phenylketonuria (PKU). For more information, please visit Synthetic Biologics' website at www.syntheticbiologics.com.                                                  

Logo - http://photos.prnewswire.com/prnh/20160105/319502LOGO

 


'/>"/>
SOURCE Synthetic Biologics, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
2. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
3. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
4. Intrexon Organizes Around New Synthetic Biology Markets
5. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
6. New England Biolabs supports iGEM synthetic biology competition
7. Synthetic Biologics to Present at OneMedForum New York 2013
8. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
9. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
10. Synthetic Biologics to Report Second Quarter 2013 Financial Results
11. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2018)... (PRWEB) , ... August 31, 2018 , ... ... research results of the impact of a proprietary biofield energy treated nutraceutical supplement ... assessed biomarkers for immune function response and blood, as well as, organ-specific inflammation. ...
(Date:8/29/2018)... N.Y. (PRWEB) , ... August 28, 2018 , ... ... leading online retailer of contact lenses, has been ranked in 1138th place on ... growing private companies. , The list represents the most successful companies within ...
(Date:8/26/2018)... South Korea (PRWEB) , ... August 24, 2018 ... ... scientific paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits ... Therapy. , According to the paper, the symptoms of mice having severe ...
(Date:8/17/2018)... ... August 16, 2018 , ... The opening of the ... acquired Chemko Technical Services in 2016. Chemko had a well established local presence, servicing ... at KSC on projects such as the ongoing work at the Mobile Launch Platform ...
Breaking Biology Technology:
(Date:8/23/2018)... ... 22, 2018 , ... Lajollacooks4u is proud to have hosted a variety of groups this year ... such as Illumina, Qualcomm, Hewlett Packard, Sequenom and more, have all visited the La Jolla-based ... , Part of the reason clientele return is due to Lajollacooks4u’s signature team-building format, a ...
(Date:8/21/2018)... (PRWEB) , ... August 21, 2018 , ... ... throughput screening (HTS) solutions, Bellbrook Labs is dedicated to offering customers a successful ... assays, visitors will find a seamless transition between products, with relevant details such ...
(Date:8/17/2018)... ... August 16, 2018 , ... Today, the FSH ... announced that its Colorado Chapter will be holding its 3rd annual Walk & ... at the Philip S. Miller Park, advocates for public awareness and is raising funds ...
Breaking Biology News(10 mins):